KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
Turnover
59%
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.24%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$782M
AUM Growth
+$192M
(+33%)
Cap. Flow
-$46.3M
Cap. Flow
% of AUM
-5.93%
Top 10 Holdings %
Top 10 Hldgs %
65.23%
Holding
93
New
24
Increased
13
Reduced
10
Closed
33
Avg Time Held Equity + Options
0.8
years
Top 10 Avg Time Held Equity + Options
0.3
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$28.9M |
| 2 |
Elevance Health
ELV
|
+$19.6M |
| 3 |
BWX Technologies
BWXT
|
+$18.1M |
| 4 |
Edwards Lifesciences
EW
|
+$13.6M |
| 5 |
Ferguson
FERG
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$19.8M |
| 2 |
Humana
HUM
|
+$19.6M |
| 3 |
Centene
CNC
|
+$13.9M |
| 4 |
Bloomin' Brands
BLMN
|
+$11.9M |
| 5 |
Chart Industries
GTLS
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.82% |
| 2 | Healthcare | 18.01% |
| 3 | Industrials | 8.99% |
| 4 | Financials | 4.7% |
| 5 | Consumer Discretionary | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| $272M | 34.84% |
762,500
+628,500
| +469% | +$250M |
2022 Q1
2 quarters
|
|
2
PUT
Invesco QQQ Trust
QQQ
$488B
| $65.5M | 8.38% |
245,000
-115,000
| -32% | -$34.7M |
2021 Q4
3 quarters
|
|
3
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$3.25B
| $29.4M | 3.77% |
500,000
+300,000
| +150% | +$18.8M |
2022 Q2
1 quarter
|
|
4
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
| $26.1M | 3.34% |
860,000
+560,000
| +187% | +$18.5M |
2022 Q2
1 quarter
|
|
|
5
Baxter International
BAX
$12.8B
| $25.9M | 3.31% |
+480,500
| New | +$28.9M |
2022 Q3
0 quarters
|
|
6
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $23.8M | 3.04% |
+300,000
| New | +$25.3M |
2022 Q3
0 quarters
|
|
|
7
Elevance Health
ELV
$92.8B
| $18.6M | 2.38% |
+41,012
| New | +$19.6M |
2022 Q3
0 quarters
|
|
|
8
BWX Technologies
BWXT
$12.3B
| $16.9M | 2.16% |
+336,000
| New | +$18.1M |
2022 Q3
0 quarters
|
|
9
DELISTED
RAPT Therapeutics
RAPT
| $16.3M | 2.08% |
84,452
-43,463
| -34% | -$8.22M |
2020 Q4
7 quarters
|
|
10
Cheniere Energy
LNG
$57.8B
| $15.1M | 1.93% |
90,975
-27,050
| -23% | -$4.1M |
2022 Q2
1 quarter
|
|
11
Palo Alto Networks
PANW
$307B
| $14.3M | 1.83% |
175,000
+55,000
| +46% | +$4.76M |
2021 Q4
3 quarters
|
|
12
Aramark
ARMK
$14.4B
| $14M | 1.8% |
623,250
+96,950
| +18% | +$2.41M |
2022 Q2
1 quarter
|
|
13
Crown Holdings
CCK
$12.1B
| $13.9M | 1.78% |
171,780
-43,700
| -20% | -$4.07M |
2022 Q1
2 quarters
|
|
14
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $13.7M | 1.75% |
+200,000
| New | +$11.8M |
2022 Q3
0 quarters
|
|
15
Amazon
AMZN
$2.74T
| $13.6M | 1.73% |
120,000
-45,000
| -27% | -$5.69M |
2021 Q1
6 quarters
|
|
16
APi Group
APG
$17.3B
| $12.6M | 1.61% |
1,424,223
-255,969
| -15% | -$2.73M |
2020 Q2
9 quarters
|
|
17
Tvardi Therapeutics
TVRD
$13.3M
| $12.5M | 1.6% |
37,028
+4,167
| +13% | +$1.51M |
2019 Q2
13 quarters
|
|
18
WillScot Mobile Mini Holdings
WSC
$2.93B
| $12.1M | 1.55% |
300,000
-26,029
| -8% | -$1.02M |
2021 Q2
5 quarters
|
|
|
19
Edwards Lifesciences
EW
$49.8B
| $11.7M | 1.49% |
+141,000
| New | +$13.6M |
2022 Q3
0 quarters
|
|
|
20
Ferguson
FERG
$43.1B
| $10.7M | 1.36% |
+103,600
| New | +$12.1M |
2022 Q3
0 quarters
|
|
21
Intercontinental Exchange
ICE
$87.1B
| $9.94M | 1.27% |
110,000
+40,000
| +57% | +$4.01M |
2022 Q2
1 quarter
|
|
22
UnitedHealth
UNH
$355B
| $9.77M | 1.25% |
+19,349
| New | +$10.2M |
2022 Q3
0 quarters
|
|
23
SL Green Realty
SLG
$3.26B
| $8.63M | 1.1% |
+215,000
| New | +$9.99M |
2022 Q3
0 quarters
|
|
24
DELISTED
OptiNose
OPTN
| $8.41M | 1.08% |
153,282
+5,949
| +4% | +$327K |
2022 Q1
2 quarters
|
|
25
PUT
Relmada Therapeutics
RLMD
$346M
| $7.4M | 0.95% |
+200,000
| New | +$5.54M |
2022 Q3
0 quarters
|
|
Similar funds
PHP
ACM
FM
PAMI
SI
ZI
RIA
PC
Kingdon Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Kingdon Capital Management held 93 positions worth $782M, up 33% from $589M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Kingdon Capital Management withdrew a net $46.3M in Q3 2022, closing 33 positions and reducing 10 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Kingdon Capital Management opened a new position in Baxter International worth $25.9M.
- Kingdon Capital Management's largest Q3 2022 buy was Baxter International: 480,500 shares worth $25.9M.
- Kingdon Capital Management added most to Palo Alto Networks in Q3 2022, an estimated $4.76M increase.
- Kingdon Capital Management's biggest Q3 2022 reduction was RAPT Therapeutics, cutting an estimated $8.22M.
- Kingdon Capital Management fully exited Meta Platforms (Facebook) in Q3 2022, selling an estimated $19.8M.
- Kingdon Capital Management's ten largest holdings make up 65% of its $782M portfolio in Q3 2022.
- Kingdon Capital Management opened 24 new positions and closed 33 in Q3 2022.
- Kingdon Capital Management's portfolio value rose 33% quarter-over-quarter to $782M.
Based on Kingdon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.